RGD-peptide modified alginate by a chemoenzymatic strategy for tissue engineering applications

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Maintaining cell function and survival post-transplantation is a key challenge in regenerative medicine.
• Alginates serve as immunoisolating biomaterials and structural supports, mimicking the extracellular matrix.

Purpose of the Study:

• To develop tailored alginates functionalized with arginine-glycine-aspartate (RGD) peptides using a chemoenzymatic strategy.
• To evaluate the impact of RGD modification on cell adhesion, survival, and function in 2D and 3D cultures.

Main Methods:

• Chemoenzymatic strategy to substitute mannuronic acid with RGD peptides on alginate.
• Carbodiimide chemistry for peptide coupling (0.1-0.2% substitution).
• Characterization using (1)H-nuclear magnetic resonance (NMR) and coal filtration.
• Culturing olfactory ensheathing cells (OECs) and myoblasts on modified and unmodified alginates in 2D and 3D.

Main Results:

• RGD-modified alginates promoted adhesion and bipolar protrusion formation in both OECs and myoblasts in 2D cultures.
• OECs survived up to 9 days in 3D cultures, indicating short-term potential.
• Myoblasts demonstrated long-term survival (up to 41 days) in 3D RGD-alginate cultures.
• RGD modification did not significantly alter cell viability in 3D cultures.

Conclusions:

• A novel chemoenzymatic technique allows precise tailoring of peptide-substituted alginates.
• These modified alginates retain gel-forming properties crucial for tissue engineering.
• RGD-functionalized alginates show potential for enhancing cell survival and function in regenerative medicine applications.